Daclizumab January 19, 2018 Daclizumab Trade Name Zenapax Orphan Indication Prevention of acute renal allograft rejection USA Market Approval USA USA Designation Date 1993-03-05 00:00:00 Sponsor Hoffmann-La Roche, Inc.;340 Kingsland Street;Nutley, New Jersey, 07110
